Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Loralee B. Rupp"'
Autor:
Philip R. Spradling, Yuna Zhong, Anne C. Moorman, Loralee B. Rupp, Mei Lu, Stuart C. Gordon, Eyasu H. Teshale, Mark A. Schmidt, Yihe G. Daida, Joseph A. Boscarino, for the Chronic Hepatitis Cohort Study (CHeCS) Investigators
Publikováno v:
Hepatology Communications, Vol 5, Iss 3, Pp 400-411 (2021)
There are limited data examining the relationship between psychosocial factors and receipt of direct‐acting antiviral (DAA) treatment among patients with hepatitis C in large health care organizations in the United States. We therefore sought to de
Externí odkaz:
https://doaj.org/article/467c1f289c0149538bddf5045cd9756d
Autor:
Ranya Selim, Stuart C. Gordon, Yueren Zhou, Talan Zhang, Mei Lu, Yihe G. Daida, Joseph A. Boscarino, Mark A. Schmidt, Sheri Trudeau, Loralee B. Rupp, Humberto C. Gonzalez
Publikováno v:
Journal of Viral Hepatitis. 30:544-550
Autor:
Philip R Spradling, Jian Xing, Yuna Zhong, Loralee B Rupp, Anne C Moorman, Mei Lu, Eyasu H Teshale, Mark A Schmidt, Yihe G Daida, Joseph A Boscarino, Stuart C Gordon
Publikováno v:
The Journal of Infectious Diseases. 226:896-900
Hepatitis B virus (HBV) infection causes hepatocellular carcinoma but its association with other cancers is not well established. We compared age-adjusted incidence of primary cancers among 5773 HBV-infected persons with US cancer registries during 2
Autor:
Yueren Zhou, Jia Li, Stuart C. Gordon, Sheri Trudeau, Loralee B. Rupp, Joseph A. Boscarino, Yihe G. Daida, Mark A. Schmidt, Mei Lu
Publikováno v:
Journal of Viral Hepatitis. 29:189-195
We investigated factors associated with rates of recommended monitoring of chronic hepatitis B (HBV) patients for viral DNA and alanine aminotransferase (ALT), and initiation of antiviral treatment among eligible patients, in a US cohort of patients
Autor:
Stuart C. Gordon, Joseph A. Boscarino, Jennifer Vincent, Jia Li, Keith D. Lindor, Robert J. Romanelli, Sheri Trudeau, Fold Investigators, Jeffrey J. VanWormer, Christopher L. Bowlus, Amandeep Sahota, Heather Anderson, Yihe G. Daida, Carla Rodriguez-Watson, Loralee B Rupp, Christina Melkonian, Kuan-Han Hank Wu, Yueren Zhou, Mei Lu, Mark A Schmidt, Irina V. Haller
Publikováno v:
Digestive Diseases and Sciences. 67:4170-4180
Ursodeoxycholic acid (UDCA) remains the first-line therapy for primary biliary cholangitis (PBC); however, inadequate treatment response (ITR) is common. The UK-PBC Consortium developed the modified UDCA Response Score (m-URS) to predict ITR (using a
Autor:
Humberto C. Gonzalez, Yueren Zhou, Faisal M. Nimri, Loralee B. Rupp, Sheri Trudeau, Stuart C. Gordon
Publikováno v:
Liver International. 42:762-764
Early reports suggest that alcohol misuse increased in 2020 as a result of the COVID-19 pandemic. Using retrospective data from Henry Ford Health System in Detroit MI-an area that experienced an early and severe COVID-19 outbreak-we investigated the
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 42(8)
Autor:
Anne C. Moorman, Mark A Schmidt, Joseph A. Boscarino, Stuart C. Gordon, Eyasu H. Teshale, Loralee B Rupp, Yuna Zhong, Yihe G. Daida, Philip R. Spradling, Mei Lu
Publikováno v:
Hepatology Communications, Vol 5, Iss 3, Pp 400-411 (2021)
Hepatology Communications
Hepatology Communications
There are limited data examining the relationship between psychosocial factors and receipt of direct‐acting antiviral (DAA) treatment among patients with hepatitis C in large health care organizations in the United States. We therefore sought to de
Autor:
Robert Wong, Loralee B. Rupp, Mei Lu, Zeyuan Yang, Yihe G. Daida, Mark A. Schmidt, Joseph A. Boscarino, Stuart Gordon, Amit Chitnis
Publikováno v:
American Journal of Gastroenterology. 117:e878-e879
Autor:
Stuart C. Gordon, Loralee B Rupp, Mark A Schmidt, Mei Lu, Yihe G. Daida, CHeCS Investigators, Yueren Zhou, Sheri Trudeau, Anne C. Moorman, Philip R. Spradling, Eyasu H. Teshale, Joseph A. Boscarino, Jia Li
Publikováno v:
J Clin Gastroenterol
Background Changing US demographics and evolving chronic hepatitis B (CHB) treatments may affect longitudinal trends in CHB-related complications. We studied trends in the prevalence of cirrhosis (past or present) and incidence of all-cause mortality
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0f3ef33b255a3cc12721598049ea963
https://europepmc.org/articles/PMC10257940/
https://europepmc.org/articles/PMC10257940/